New appropriate use criteria for somatostatin receptor PET imaging in NETs

05 Jan 2018


The Society for Nuclear Medicine and Molecular Imaging has developed and published appropriate use criteria for somatostatin PET imaging that includes different clinical scenarios for diagnosing neuroendocrine tumours.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story